160 related articles for article (PubMed ID: 34802165)
1. NLRC5 enhances autophagy via inactivation of AKT/mTOR pathway and ameliorates cardiac hypertrophy.
Ba B; Mayila A; Guo Y; Xu J; Xing S; Cao G
Int J Exp Pathol; 2022 Feb; 103(1):23-30. PubMed ID: 34802165
[TBL] [Abstract][Full Text] [Related]
2. G Protein-Coupled Estrogen Receptor 1 Inhibits Angiotensin II-Induced Cardiomyocyte Hypertrophy via the Regulation of PI3K-Akt-mTOR Signalling and Autophagy.
Pei H; Wang W; Zhao D; Su H; Su G; Zhao Z
Int J Biol Sci; 2019; 15(1):81-92. PubMed ID: 30662349
[TBL] [Abstract][Full Text] [Related]
3. Indoleamine 2,3-Dioxygenase 1 (IDO1) Promotes Cardiac Hypertrophy via a PI3K-AKT-mTOR-Dependent Mechanism.
Liu Y; Li S; Gao Z; Li S; Tan Q; Li Y; Wang D; Wang Q
Cardiovasc Toxicol; 2021 Aug; 21(8):655-668. PubMed ID: 34021461
[TBL] [Abstract][Full Text] [Related]
4. Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways.
Ba L; Gao J; Chen Y; Qi H; Dong C; Pan H; Zhang Q; Shi P; Song C; Guan X; Cao Y; Sun H
Phytomedicine; 2019 May; 58():152765. PubMed ID: 31005720
[TBL] [Abstract][Full Text] [Related]
5. YQFM alleviated cardiac hypertrophy by apoptosis inhibition and autophagy regulation via PI
Wan M; Yin K; Yuan J; Ma S; Xu Q; Li D; Gao H; Gou X
J Ethnopharmacol; 2022 Mar; 285():114835. PubMed ID: 34798161
[TBL] [Abstract][Full Text] [Related]
6. PKD deletion promotes autophagy and inhibits hypertrophy in cardiomyocyte.
Zhao D; Gao Y; Wang W; Pei H; Xu C; Zhao Z
Exp Cell Res; 2020 Jan; 386(2):111742. PubMed ID: 31759056
[TBL] [Abstract][Full Text] [Related]
7. Hexarelin protects cardiac H9C2 cells from angiotensin II-induced hypertrophy
Agbo E; Li MX; Wang YQ; Saahene RO; Massaro J; Tian GZ
Pharmazie; 2019 Aug; 74(8):485-491. PubMed ID: 31526442
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA FTX Reduces Hypertrophy of Neonatal Mouse Cardiac Myocytes and Regulates the PTEN/PI3K/Akt Signaling Pathway by Sponging MicroRNA-22.
Yang X; Tao L; Zhu J; Zhang S
Med Sci Monit; 2019 Dec; 25():9609-9617. PubMed ID: 31840653
[TBL] [Abstract][Full Text] [Related]
9. HTR2A promotes the development of cardiac hypertrophy by activating PI3K-PDK1-AKT-mTOR signaling.
Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K
Cell Stress Chaperones; 2020 Nov; 25(6):899-908. PubMed ID: 32519137
[TBL] [Abstract][Full Text] [Related]
10. Effect of endostatin overexpression on angiotensin II-induced cardiac hypertrophy in rats.
Dai YJ; Gong JX; Bian R
Chin Med J (Engl); 2019 Nov; 132(22):2716-2723. PubMed ID: 31725448
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy.
Xu X; Su YL; Shi JY; Lu Q; Chen C
Cardiovasc Toxicol; 2021 Sep; 21(9):759-771. PubMed ID: 34120306
[TBL] [Abstract][Full Text] [Related]
12. Mibefradil Alleviates High-Glucose-induced Cardiac Hypertrophy by Inhibiting PI3K/Akt/mTOR-mediated Autophagy.
Zhao LG; Li PL; Dai Y; Deng JL; Shan MY; Chen B; Zhang KB; Guo SD; Xu ZH
J Cardiovasc Pharmacol; 2020 Aug; 76(2):246-254. PubMed ID: 32433360
[TBL] [Abstract][Full Text] [Related]
13. Ginkgolide B Protects Cardiomyocytes from Angiotensin II-Induced Hypertrophy via Regulation of Autophagy through SIRT1-FoxO1.
Jiang Q; Lu M; Li J; Zhu Z
Cardiovasc Ther; 2021; 2021():5554569. PubMed ID: 34257705
[TBL] [Abstract][Full Text] [Related]
14. Soluble epoxide hydrolase inhibitor, TUPS, attenuates isoproterenol/angiotensin II-induced cardiac hypertrophy through mammalian target of rapamycin-mediated autophagy inhibition.
Zhang H; Zhang K; Liang J; Yan W; Wu F; Xu W; Wu Z; Chen Y; Pan R; Wu G
J Pharm Pharmacol; 2019 Aug; 71(8):1291-1300. PubMed ID: 31215026
[TBL] [Abstract][Full Text] [Related]
15. MiR-181a mediates Ang II-induced myocardial hypertrophy by mediating autophagy.
Li AL; Lv JB; Gao L
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5462-5470. PubMed ID: 29243791
[TBL] [Abstract][Full Text] [Related]
16. miR-29a promotes pathological cardiac hypertrophy by targeting the PTEN/AKT/mTOR signalling pathway and suppressing autophagy.
Shi JY; Chen C; Xu X; Lu Q
Acta Physiol (Oxf); 2019 Oct; 227(2):e13323. PubMed ID: 31162869
[TBL] [Abstract][Full Text] [Related]
17. 3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α.
Zong J; Wu QQ; Zhou H; Zhang JY; Yuan Y; Bian ZY; Deng W; Dai J; Li FF; Xu M; Fang Y; Tang QZ
Mol Med Rep; 2015 Jul; 12(1):1247-52. PubMed ID: 25816057
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.
Diniz GP; Carneiro-Ramos MS; Barreto-Chaves ML
Basic Res Cardiol; 2009 Nov; 104(6):653-67. PubMed ID: 19588183
[TBL] [Abstract][Full Text] [Related]
19. Deciphering the effective combinatorial components from Si-Miao-Yong-An decoction regarding the intervention on myocardial hypertrophy.
Chen XY; Chen XH; Li L; Su CP; Zhang YL; Jiang YY; Guo SZ; Liu B
J Ethnopharmacol; 2021 May; 271():113833. PubMed ID: 33465437
[TBL] [Abstract][Full Text] [Related]
20. Exogenous cathepsin V protein protects human cardiomyocytes HCM from angiotensin Ⅱ-Induced hypertrophy.
Huang K; Gao L; Yang M; Wang J; Wang Z; Wang L; Wang G; Li H
Int J Biochem Cell Biol; 2017 Aug; 89():6-15. PubMed ID: 28522343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
